U.S. advisers back experimental obesity pill
SILVER SPRING, Maryland (Reuters) - An experimental obesity drug from Vivus Inc won the backing of a U.S. advisory panel on Wednesday, raising hopes regulators would approve a weight-loss pill for the first time in 13 years. A panel of outside experts to the Food and Drug Administration voted 20-2 to recommend approval of Qnexa, meant to treat obesity and its accompanying health problems. The FDA rejected Vivus' Qnexa in 2010 because of safety concerns related to heart rate and birth defects, along with two other obesity pills that are also seeking a second round of consideration. ... read more..
source:http://yhoo.it/y9OzOL
No comments:
Post a Comment